15 research outputs found

    Base moléculaire des effets de l'huile d'argan sur le métabolisme mitochondrial et peroxysomal des acides gras et sur l'inflammation

    Get PDF
    L objectif des travaux de cette thĂšse a Ă©tĂ© d explorer les bases molĂ©culaires de l effet de l huile d Argan (HA) sur le mĂ©tabolisme lipidique au niveau mitochondriale et peroxysomale ainsi qu Ă©lucider son potentiel anti-inflammatoire. Nous avons donc montrĂ©, dans un premier temps, que les mĂ©thodes artisanales prĂ©servaient les propriĂ©tĂ©s antioxydantes d HA empĂȘchant l oxydation de l acide fĂ©rulique contrairement Ă  l HA d origines commerciale. Ensuite, le traitement par l HA ou par les lipopolysaccharides (LPS) de fibroblastes humains, un modĂšle cellulaire de la pseudo-adrĂ©noleucodystrophie nĂ©onatale (P-NALD), rĂ©vĂšle pour l HA une prolifĂ©ration des peroxysomes indĂ©pendante de l activation du rĂ©cepteur nuclĂ©aire PPARa et de son coactivateur PGC-1a. Par contre, l induction de la prolifĂ©ration de peroxysomes par les LPS est accompagnĂ©e d une activation de PPAR et de PGC-1 ParallĂšlement, une Ă©tude a Ă©tĂ© rĂ©alisĂ©e au niveau hĂ©patique chez des souris traitĂ©es par l HA ou par les LPS. Nous avons montrĂ© pour la premiĂšre fois l activitĂ© antioxydante de l huile d Argan in vivo au niveau hĂ©patique par l induction de l activitĂ© enzymatique de la catalase peroxysomale et une activitĂ© hypolipĂ©miante par la stimulation des activitĂ©s dĂ©shydrogĂ©nases (ACADs) de la -oxydations mitochondriale des acides gars. De plus, l HA induit la transcription des gĂšnes PPECK et G6PH de la voie de la nĂ©oglucogenĂšse. Nous avons montrĂ© Ă©galement pour la premiĂšre fois un effet prĂ©ventif de l HA contre la rĂ©pression des activitĂ©s dĂ©shydrogĂ©nases des voies de -oxydations mitochondriale et peroxysomale, ainsi que celle la voie de la nĂ©oglucogenĂšse. Nos travaux dĂ©montrent que l HA possĂšde un potentiel anti-inflammatoire, induit par le LPS, Ă©lucidĂ© par la rĂ©pression de cytokines pro-inflammatoires IL-6 et TNFa et par l induction de cytokines anti-inflammatoires IL10 et IL-4. L ensemble de nos rĂ©sultats indiquerait que l huile d Argan, du fait de sa composition riche en acide gras mono et polyinsaturĂ©s et en antioxydants, a des effets hypolipĂ©miants et anti-inflammatoires au niveau hĂ©patique qui se traduisent par une rĂ©gulation de l expression Ă  la fois de rĂ©cepteurs nuclĂ©aires et de leur gĂšnes cibles ainsi que de certaines cytokinesThe objective of this thesis work was to explore the molecular basis of Argan Oil (AO) effects on the mitochondrial and peroxisomal lipid metabolism and to elucidate its anti-inflammatory potential. We thus showed, initially, that the artisanal method preparation preserved the antioxidant properties of AO preventing the oxidation of the ferulic acid, by contrast to AO of commercial origin. Then, the treatment by the AO or lipopolysaccharides (LPS) of human fibroblasts, the cellular model of pseudo-neonatal adrenoleukodystrophy (P-NALD), revealed for the AO that peroxisomes proliferation is independent from the activation of the nuclear receptor PPARa and the co-activator PGC-1a. On the other side, the induction of the proliferation of peroxisomes by LPS is accompanied by an activation of both PPARa and PGC-1a. At the same time, mice treatments by AO or by the LPS showed, for the first time, the hepatic antioxidant activity of AO through the induction of the activity of the peroxisomal catalase. In addition, we showed a hypolipidemic activity of AO, by the stimulation of dehydrogenase activities (ACADs) of the mitochondrial fatty acid b-oxidation. Moreover, the AO induces the transcription of genes involved in gluconeogenesis pathway (i.e. PEPCK and G6PH). We also revealed, for the first time, the preventive effect of AO against LPS repressions of mitochondrial and peroxisomal fatty acid degradation as well as on the gluconeogenic pathway. Furthermore, the AO anti-inflammatory potential has been shown, in mice treated by LPS, through the repression of the pro-inflammatory cytokines IL-6 and TNFa and by the induction of the anti-inflammatory cytokines IL10 and IL-4. All together, our results may indicate that the Argan oil, because of its composition rich in mono and polyunsaturated fatty acids and in antioxidants as well, has a hypolipidemic and an anti-inflammatory effects, which are revealed by the regulation of the expressions of nuclear receptors and their target genes including several cytokinesDIJON-BU Doc.Ă©lectronique (212319901) / SudocSudocFranceF

    Base moléculaire des effets de l'huile d'argan sur le métabolisme mitochondrial et peroxysomal des acides gras et sur l'inflammation

    No full text
    The objective of this thesis work was to explore the molecular basis of Argan Oil (AO) effects on the mitochondrial and peroxisomal lipid metabolism and to elucidate its anti-inflammatory potential. We thus showed, initially, that the artisanal method preparation preserved the antioxidant properties of AO preventing the oxidation of the ferulic acid, by contrast to AO of commercial origin. Then, the treatment by the AO or lipopolysaccharides (LPS) of human fibroblasts, the cellular model of pseudo-neonatal adrenoleukodystrophy (P-NALD), revealed for the AO that peroxisomes proliferation is independent from the activation of the nuclear receptor PPARα and the co-activator PGC-1α. On the other side, the induction of the proliferation of peroxisomes by LPS is accompanied by an activation of both PPARα and PGC-1α. At the same time, mice treatments by AO or by the LPS showed, for the first time, the hepatic antioxidant activity of AO through the induction of the activity of the peroxisomal catalase. In addition, we showed a hypolipidemic activity of AO, by the stimulation of dehydrogenase activities (ACADs) of the mitochondrial fatty acid b-oxidation. Moreover, the AO induces the transcription of genes involved in gluconeogenesis pathway (i.e. PEPCK and G6PH). We also revealed, for the first time, the preventive effect of AO against LPS repressions of mitochondrial and peroxisomal fatty acid degradation as well as on the gluconeogenic pathway. Furthermore, the AO anti-inflammatory potential has been shown, in mice treated by LPS, through the repression of the pro-inflammatory cytokines IL-6 and TNFα and by the induction of the anti-inflammatory cytokines IL10 and IL-4. All together, our results may indicate that the Argan oil, because of its composition rich in mono and polyunsaturated fatty acids and in antioxidants as well, has a hypolipidemic and an anti-inflammatory effects, which are revealed by the regulation of the expressions of nuclear receptors and their target genes including several cytokinesL’objectif des travaux de cette thĂšse a Ă©tĂ© d’explorer les bases molĂ©culaires de l’effet de l’huile d’Argan (HA) sur le mĂ©tabolisme lipidique au niveau mitochondriale et peroxysomale ainsi qu’élucider son potentiel anti-inflammatoire. Nous avons donc montrĂ©, dans un premier temps, que les mĂ©thodes artisanales prĂ©servaient les propriĂ©tĂ©s antioxydantes d’HA empĂȘchant l’oxydation de l’acide fĂ©rulique contrairement Ă  l’HA d’origines commerciale. Ensuite, le traitement par l‘HA ou par les lipopolysaccharides (LPS) de fibroblastes humains, un modĂšle cellulaire de la pseudo-adrĂ©noleucodystrophie nĂ©onatale (P-NALD), rĂ©vĂšle pour l’HA une prolifĂ©ration des peroxysomes indĂ©pendante de l’activation du rĂ©cepteur nuclĂ©aire PPARα et de son coactivateur PGC-1α. Par contre, l’induction de la prolifĂ©ration de peroxysomes par les LPS est accompagnĂ©e d’une activation de PPAR et de PGC-1ParallĂšlement, une Ă©tude a Ă©tĂ© rĂ©alisĂ©e au niveau hĂ©patique chez des souris traitĂ©es par l‘HA ou par les LPS. Nous avons montrĂ© pour la premiĂšre fois l’activitĂ© antioxydante de l’huile d’Argan in vivo au niveau hĂ©patique par l’induction de l’activitĂ© enzymatique de la catalase peroxysomale et une activitĂ© hypolipĂ©miante par la stimulation des activitĂ©s dĂ©shydrogĂ©nases (ACADs) de la -oxydations mitochondriale des acides gars. De plus, l’HA induit la transcription des gĂšnes PPECK et G6PH de la voie de la nĂ©oglucogenĂšse. Nous avons montrĂ© Ă©galement pour la premiĂšre fois un effet prĂ©ventif de l’HA contre la rĂ©pression des activitĂ©s dĂ©shydrogĂ©nases des voies de -oxydations mitochondriale et peroxysomale, ainsi que celle la voie de la nĂ©oglucogenĂšse. Nos travaux dĂ©montrent que l’HA possĂšde un potentiel anti-inflammatoire, induit par le LPS, Ă©lucidĂ© par la rĂ©pression de cytokines pro-inflammatoires IL-6 et TNFα et par l’induction de cytokines anti-inflammatoires IL10 et IL-4. L’ensemble de nos rĂ©sultats indiquerait que l’huile d’Argan, du fait de sa composition riche en acide gras mono et polyinsaturĂ©s et en antioxydants, a des effets hypolipĂ©miants et anti-inflammatoires au niveau hĂ©patique qui se traduisent par une rĂ©gulation de l’expression Ă  la fois de rĂ©cepteurs nuclĂ©aires et de leur gĂšnes cibles ainsi que de certaines cytokine

    Molecular basis of the effects of argan oil on mitochondrial and peroxisomal metabolism of the fatty acids and inflammation

    No full text
    L’objectif des travaux de cette thĂšse a Ă©tĂ© d’explorer les bases molĂ©culaires de l’effet de l’huile d’Argan (HA) sur le mĂ©tabolisme lipidique au niveau mitochondriale et peroxysomale ainsi qu’élucider son potentiel anti-inflammatoire. Nous avons donc montrĂ©, dans un premier temps, que les mĂ©thodes artisanales prĂ©servaient les propriĂ©tĂ©s antioxydantes d’HA empĂȘchant l’oxydation de l’acide fĂ©rulique contrairement Ă  l’HA d’origines commerciale. Ensuite, le traitement par l‘HA ou par les lipopolysaccharides (LPS) de fibroblastes humains, un modĂšle cellulaire de la pseudo-adrĂ©noleucodystrophie nĂ©onatale (P-NALD), rĂ©vĂšle pour l’HA une prolifĂ©ration des peroxysomes indĂ©pendante de l’activation du rĂ©cepteur nuclĂ©aire PPARα et de son coactivateur PGC-1α. Par contre, l’induction de la prolifĂ©ration de peroxysomes par les LPS est accompagnĂ©e d’une activation de PPAR et de PGC-1ParallĂšlement, une Ă©tude a Ă©tĂ© rĂ©alisĂ©e au niveau hĂ©patique chez des souris traitĂ©es par l‘HA ou par les LPS. Nous avons montrĂ© pour la premiĂšre fois l’activitĂ© antioxydante de l’huile d’Argan in vivo au niveau hĂ©patique par l’induction de l’activitĂ© enzymatique de la catalase peroxysomale et une activitĂ© hypolipĂ©miante par la stimulation des activitĂ©s dĂ©shydrogĂ©nases (ACADs) de la -oxydations mitochondriale des acides gars. De plus, l’HA induit la transcription des gĂšnes PPECK et G6PH de la voie de la nĂ©oglucogenĂšse. Nous avons montrĂ© Ă©galement pour la premiĂšre fois un effet prĂ©ventif de l’HA contre la rĂ©pression des activitĂ©s dĂ©shydrogĂ©nases des voies de -oxydations mitochondriale et peroxysomale, ainsi que celle la voie de la nĂ©oglucogenĂšse. Nos travaux dĂ©montrent que l’HA possĂšde un potentiel anti-inflammatoire, induit par le LPS, Ă©lucidĂ© par la rĂ©pression de cytokines pro-inflammatoires IL-6 et TNFα et par l’induction de cytokines anti-inflammatoires IL10 et IL-4. L’ensemble de nos rĂ©sultats indiquerait que l’huile d’Argan, du fait de sa composition riche en acide gras mono et polyinsaturĂ©s et en antioxydants, a des effets hypolipĂ©miants et anti-inflammatoires au niveau hĂ©patique qui se traduisent par une rĂ©gulation de l’expression Ă  la fois de rĂ©cepteurs nuclĂ©aires et de leur gĂšnes cibles ainsi que de certaines cytokinesThe objective of this thesis work was to explore the molecular basis of Argan Oil (AO) effects on the mitochondrial and peroxisomal lipid metabolism and to elucidate its anti-inflammatory potential. We thus showed, initially, that the artisanal method preparation preserved the antioxidant properties of AO preventing the oxidation of the ferulic acid, by contrast to AO of commercial origin. Then, the treatment by the AO or lipopolysaccharides (LPS) of human fibroblasts, the cellular model of pseudo-neonatal adrenoleukodystrophy (P-NALD), revealed for the AO that peroxisomes proliferation is independent from the activation of the nuclear receptor PPARα and the co-activator PGC-1α. On the other side, the induction of the proliferation of peroxisomes by LPS is accompanied by an activation of both PPARα and PGC-1α. At the same time, mice treatments by AO or by the LPS showed, for the first time, the hepatic antioxidant activity of AO through the induction of the activity of the peroxisomal catalase. In addition, we showed a hypolipidemic activity of AO, by the stimulation of dehydrogenase activities (ACADs) of the mitochondrial fatty acid b-oxidation. Moreover, the AO induces the transcription of genes involved in gluconeogenesis pathway (i.e. PEPCK and G6PH). We also revealed, for the first time, the preventive effect of AO against LPS repressions of mitochondrial and peroxisomal fatty acid degradation as well as on the gluconeogenic pathway. Furthermore, the AO anti-inflammatory potential has been shown, in mice treated by LPS, through the repression of the pro-inflammatory cytokines IL-6 and TNFα and by the induction of the anti-inflammatory cytokines IL10 and IL-4. All together, our results may indicate that the Argan oil, because of its composition rich in mono and polyunsaturated fatty acids and in antioxidants as well, has a hypolipidemic and an anti-inflammatory effects, which are revealed by the regulation of the expressions of nuclear receptors and their target genes including several cytokine

    Peroxisomal Acyl-CoA Oxidase Type 1: Anti-Inflammatory and Anti-Aging Properties with a Special Emphasis on Studies with LPS and Argan Oil as a Model Transposable to Aging

    No full text
    To clarify appropriateness of current claims for health and wellness virtues of argan oil, studies were conducted in inflammatory states. LPS induces inflammation with reduction of PGC1-α signaling and energy metabolism. Argan oil protected the liver against LPS toxicity and interestingly enough preservation of peroxisomal acyl-CoA oxidase type 1 (ACOX1) activity against depression by LPS. This model of LPS-driven toxicity circumvented by argan oil along with a key anti-inflammatory role attributed to ACOX1 has been here transposed to model aging. This view is consistent with known physiological role of ACOX1 in yielding precursors of specialized proresolving mediators (SPM) and with characteristics of aging and related disorders including reduced PGC1-α function and improvement by strategies rising ACOX1 (via hormonal gut FGF19 and nordihydroguaiaretic acid in metabolic syndrome and diabetes conditions) and SPM (neurodegenerative disorders, atherosclerosis, and stroke). Delay of aging to resolve inflammation results from altered production of SPM, SPM improving most aging disorders. The strategic metabolic place of ACOX1, upstream of SPM biosynthesis, along with ability of ACOX1 preservation/induction and SPM to improve aging-related disorders and known association of aging with drop in ACOX1 and SPM, all converge to conclude that ACOX1 represents a previously unsuspected and currently emerging antiaging protein

    Protective Effect of Argan and Olive Oils against LPS-Induced Oxidative Stress and Inflammation in Mice Livers.

    No full text
    International audienceSepsis causes severe dysregulation of organ functions, via the development of oxidative stress and inflammation. These pathophysiological mechanisms are mimicked in mice injected with bacterial lipopolysaccharide (LPS). Here, protective properties of argan oil against LPS-induced oxidative stress and inflammation are explored in the murine model. Mice received standard chow, supplemented with argan oil (AO) or olive oil (OO) for 25 days, before septic shock was provoked with a single intraperitoneal injection of LPS, 16 hours prior to animal sacrifice. In addition to a rise in oxidative stress and inflammatory markers, injected LPS also caused hepatotoxicity, accompanied by hyperglycemia, hypercholesterolemia and hyperuremia. These LPS-associated toxic effects were blunted by AO pretreatment, as corroborated by normal plasma parameters and cell stress markers (glutathione: GSH) and antioxidant enzymology (catalase, CAT; superoxide dismutase, SOD and glutathione peroxidase, GPx). Hematoxylin–eosin staining revealed that AO can protect against acute liver injury, maintaining a normal status, which is pointed out by absent or reduced LPS-induced hepatic damage markers (i.e., alanine aminotransferase (ALT) and aspartate transaminase (AST)). Our work also indicated that AO displayed anti-inflammatory activity, due to down-regulations of genes encoding pro-inflammatory cytokines Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and in up-regulations of the expression of anti-inflammatory genes encoding Interleukin-4 (IL-4) and Interleukin-10 (IL-10). OO provided animals with similar, though less extensive, protective changes. Collectively our work adds compelling evidence to the protective mechanisms of AO against LPS-induced liver injury and hence therapeutic potentialities, in regard to the management of human sepsis. Activations of IL-4/Peroxisome Proliferator-Activated Receptors (IL-4/PPARs) signaling and, under LPS, an anti-inflammatory IL-10/Liver X Receptor (IL-10/LXR) route, obviously indicated the high potency and plasticity of the anti-inflammatory properties of argan oil

    Biological activities of Schottenol and Spinasterol, two natural phytosterols present in argan oil and in cactus pear seed oil, on murine miroglial BV2 cells

    No full text
    International audienceThe objective of this study was to evaluate the biological activities of the major phytosterols present in argan oil (AO) and in cactus seed oil (CSO) in BV2 microglial cells. Accordingly, we first determined the sterol composition of AO and CSO, showing the presence of Schottenol and Spinasterol as major sterols in AO. While in CSO, in addition to these two sterols, we found mainly another sterol, the Sitosterol. The chemical synthesis of Schottenol and Spinasterol was performed. Our results showed that these two phytosterols, as well as sterol extracts from AO or CSO, are not toxic to microglial BV2 cells. However, treatments by these phytosterols impact the mitochondrial membrane potential. Furthermore, both Schottenol and Spinasterol can modulate the gene expression of two nuclear receptors, liver X receptor (LXR)-alpha and LXR beta, their target genes ABCA1 and ABCG1. Nonetheless, only Schottenol exhibited a differential activation vis-a-vis the nuclear receptor LXR beta. Thus Schottenol and Spinasterol can be considered as new LXR agonists, which may play protective roles by the modulation of cholesterol metabolism

    The Promise of Piperine in Cancer Chemoprevention

    No full text
    Cancer, characterized by the unregulated growth and dissemination of malignantly transformed cells, presents a significant global health challenge. The multistage process of cancer development involves intricate biochemical and genetic alterations within target cells. Cancer chemoprevention has emerged as a vital strategy to address this complex issue to mitigate cancer’s impact on healthcare systems. This approach leverages pharmacologically active agents to block, suppress, prevent, or reverse invasive cancer development. Among these agents, piperine, an active alkaloid with a wide range of therapeutic properties, including antioxidant, anti-inflammatory, and immunomodulatory effects, has garnered attention for its potential in cancer prevention and treatment. This comprehensive review explores piperine’s multifaceted role in inhibiting the molecular events and signaling pathways associated with various stages of cancer development, shedding light on its promising prospects as a versatile tool in cancer chemoprevention. Furthermore, the review will also delve into how piperine enhances the effectiveness of conventional treatments such as UV-phototherapy and TRAIL-based therapy, potentially synergizing with existing therapeutic modalities to provide more robust cancer management strategies. Finally, a crucial perspective of the long-term safety and potential side effects of piperine-based therapies and the need for clinical trials is also discussed

    Argan oil prevents down-regulation induced by endotoxin on liver fatty acid oxidation and gluconeogenesis and on peroxisome proliferator-activated receptor gamma coactivator-1 alpha, (PGC-1alpha), peroxisome proliferator-activated receptor gamma (PPARgamma) and estrogen related receptor alpha (ERRalpha)

    No full text
    International audienceIn patients with sepsis, liver metabolism and its capacity to provide other organs with energeticsubstrates are impaired. This and many other pathophysiological changes seen in human patients arereproduced in mice injected with purified endotoxin (lipopolysaccharide, LPS). In the present study,down-regulation of genes involved in hepatic fatty acid oxidation (FAOx) and gluconeogenesis in miceexposed to LPS was challenged by nutritional intervention with argan oil. Mice given a standard chowsupplemented or not with either 6% (w/w) argan oil (AO) or 6% (w/w) olive oil (OO) prior toexposure to LPS were explored for liver gene expressions and enzyme activities. LPS-treated micewere protected by nutritional AO or OO supplementations against down-regulations of hepatic FAOxand gluconeogenesis. Underlying mechanisms lied in a prevention of sepsis-associated drops in hepaticexpressions of nuclear receptors PPARα and ERRα and coactivator PGC-1α. These preventive mechanisms conveyed by AO against LPS-induced metabolic dysregulation might add new therapeuticpotentialities in the management of human sepsis

    Peroxisomal acyl-coa oxidase type 1: anti-inflammatory and anti-aging properties with a special emphasis on studies with lps and argan oil as a model transposable to aging

    Get PDF
    International audienceTo clarify appropriateness of current claims for health and wellness virtues of argan oil, studies were conducted in inflammatory states. LPS induces inflammation with reduction of PGC1-α signaling and energy metabolism. Argan oil protected the liver against LPS toxicity and interestingly enough preservation of peroxisomal acyl-CoA oxidase type 1 (ACOX1) activity against depression by LPS. This model of LPS-driven toxicity circumvented by argan oil along with a key anti-inflammatory role attributed to ACOX1 has been here transposed to model aging. This view is consistent with known physiological role of ACOX1 in yielding precursors of specialized proresolving mediators (SPM) and with characteristics of aging and related disorders including reduced PGC1-α function and improvement by strategies rising ACOX1 (via hormonal gut FGF19 and nordihydroguaiaretic acid in metabolic syndrome and diabetes conditions) and SPM (neurodegenerative disorders, atherosclerosis, and stroke). Delay of aging to resolve inflammation results from altered production of SPM, SPM improving most aging disorders. The strategic metabolic place of ACOX1, upstream of SPM biosynthesis, along with ability of ACOX1 preservation/induction and SPM to improve aging-related disorders and known association of aging with drop in ACOX1 and SPM, all converge to conclude that ACOX1 represents a previously unsuspected and currently emerging antiaging protein
    corecore